The evidence-based medicine paradigm: where are we 20 years later? Part 1
- PMID: 23786728
- DOI: 10.1017/s0317167100014542
The evidence-based medicine paradigm: where are we 20 years later? Part 1
Abstract
The evidence-based medicine (EBM) paradigm, introduced in 1992, has had a major and positive impact on all aspects of health care. However, widespread use has also uncovered some limitations; these are discussed from the perspectives of two clinicians in this, the first of a two part narrative review. For example, there are credible reservations about the validity of hierarchical levels of evidence, a core element of the EBM paradigm. In addition, potential and actual methodological and statistical deficiencies have been identified, not only in many published randomized controlled trials but also in systematic reviews, both rated highly for evidence in EBM classifications. Ethical violations compromise reliability of some data. Clinicians need to be conscious of potential limitations in some of the cornerstones of the EBM paradigm, and to deficiencies in the literature.
Comment in
- Can J Neurol Sci. 2014 Jan;41(1):129
-
Evidence-based medicine 20 years on: a view from the inside.Can J Neurol Sci. 2013 Jul;40(4):448-9. doi: 10.1017/s0317167100014499. Can J Neurol Sci. 2013. PMID: 23786723 No abstract available.
-
To the editor.Can J Neurol Sci. 2014 Jan;41(1):128-9. doi: 10.1017/s0317167100016437. Can J Neurol Sci. 2014. PMID: 24384354 No abstract available.
-
Response to the Letter to the Editor.Can J Neurol Sci. 2014 Jan;41(1):129. doi: 10.1017/s0317167100017479. Can J Neurol Sci. 2014. PMID: 26693536 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
